Authors
Loading...
Demonstrates dual-immunotherapy triggers tumor cell death in bladder cancer, implying innovative therapeutic strategies.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: